Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024
Inspire Medical Systems, Inc. (NYSE: INSP) has announced it will release its third quarter 2024 financial results after the market closes on Monday, November 4, 2024. The company's management team will host a conference call at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
Investors can access the earnings call webcast through the Investor Relations page of Inspire's website or via a provided link. Those planning to ask questions during the call should register using a separate link. Registration is recommended at least 10 minutes before the call starts. A replay of the call will be available on the company's Investor Relations website approximately two hours after the event and will be archived for two weeks.
Inspire Medical Systems, Inc. (NYSE: INSP) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 dopo la chiusura del mercato il lunedì 4 novembre 2024. Il team di gestione dell'azienda ospiterà una conference call alle 17:00 ora orientale per discutere i risultati finanziari e i recenti sviluppi aziendali.
Gli investitori possono accedere al webcast della call sugli utili attraverso la pagina delle Relazioni con gli Investitori del sito web di Inspire o tramite un link fornito. Coloro che intendono fare domande durante la call devono registrarsi utilizzando un link separato. Si consiglia di registrarsi almeno 10 minuti prima dell'inizio della call. Una registrazione della call sarà disponibile sul sito web delle Relazioni con gli Investitori dell'azienda circa due ore dopo l'evento e sarà archiviata per due settimane.
Inspire Medical Systems, Inc. (NYSE: INSP) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 después del cierre del mercado el lunes 4 de noviembre de 2024. El equipo de gestión de la empresa llevará a cabo una conferencia telefónica a las 5:00 p.m., hora del Este, para discutir los resultados financieros y los recientes desarrollos empresariales.
Los inversores pueden acceder a la transmisión en vivo de la llamada de ganancias a través de la página de Relaciones con los Inversores del sitio web de Inspire o a través de un enlace proporcionado. Aquellos que planeen hacer preguntas durante la llamada deben registrarse usando un enlace separado. Se recomienda registrarse al menos 10 minutos antes de que comience la llamada. Una repetición de la llamada estará disponible en el sitio web de Relaciones con los Inversores de la empresa aproximadamente dos horas después del evento y se archivará durante dos semanas.
인스파이어 메디컬 시스템즈, 주식회사 (NYSE: INSP)는 2024년 3분기 재무 실적을 2024년 11월 4일 월요일 시장 종료 후 발표할 것이라고 밝혔다. 회사의 경영팀은 동부 표준시 오후 5:00에 재무 실적 및 최근 사업 개발에 대해 논의하는 컨퍼런스 콜을 진행할 예정이다.
투자자는 인스파이어 웹사이트의 투자자 관계 페이지를 통해 또는 제공된 링크를 통해 수익 전화회의 웹캐스트에 접근할 수 있다. 통화 중 질문할 예정인 사람은 별도의 링크를 사용하여 등록해야 한다. 통화 시작 10분 전에 등록하는 것이 권장된다. 통화의 재생은 이벤트 후 약 2시간이 지나면 회사의 투자자 관계 웹사이트에 제공되며, 2주 동안 아카이브된다.
Inspire Medical Systems, Inc. (NYSE: INSP) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 après la fermeture du marché le lundi 4 novembre 2024. L'équipe de direction de la société animera une conférence téléphonique à 17h00, heure de l'Est, pour discuter des résultats financiers et des récents développements commerciaux.
Les investisseurs peuvent accéder à la diffusion en direct de l'appel de résultats via la page des Investisseurs du site Web d'Inspire ou via un lien fourni. Ceux qui prévoient de poser des questions lors de l'appel doivent s'inscrire en utilisant un lien séparé. Il est recommandé de s'inscrire au moins 10 minutes avant le début de l'appel. Un enregistrement de l'appel sera disponible sur le site des Relations avec les Investisseurs de l'entreprise environ deux heures après l'événement et sera archivé pendant deux semaines.
Inspire Medical Systems, Inc. (NYSE: INSP) hat angekündigt, dass die Finanzergebnisse des dritten Quartals 2024 nach Börsenschluss am Montag, den 4. November 2024 veröffentlicht werden. Das Management-Team des Unternehmens wird um 17:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Finanzergebnisse und die jüngsten Geschäftsentwicklungen zu besprechen.
Investoren können über die Investor-Relations-Seite der Website von Inspire oder über einen bereitgestellten Link auf das Webcast der Telefonkonferenz zugreifen. Diejenigen, die während der Konferenz Fragen stellen möchten, sollten sich über einen separaten Link registrieren. Eine Registrierung wird empfohlen, mindestens 10 Minuten vor Beginn der Konferenz. Eine Aufzeichnung der Konferenz wird etwa zwei Stunden nach der Veranstaltung auf der Investor-Relations-Website des Unternehmens verfügbar sein und für zwei Wochen archiviert werden.
- None.
- None.
MINNEAPOLIS, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2024 after the close of trading on Monday, November 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q3 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.
If you plan to ask a question, please use the following link: Inspire's Q3 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.
Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
When will Inspire Medical Systems (INSP) release its Q3 2024 financial results?
What time is Inspire Medical Systems' (INSP) Q3 2024 earnings call scheduled for?
How can investors access Inspire Medical Systems' (INSP) Q3 2024 earnings call?
Will there be a replay available for Inspire Medical Systems' (INSP) Q3 2024 earnings call?
